
With the advent of new therapeutic zzso the treatment options for zzso can vary greatly depending upon the aggressiveness of the patient's zzso Patients may receive no therapy, zzso therapy, aggressive zzso therapy zzso zzso zzso zzso therapy zzso zzso or bone zzso zzso It is now mandatory to determine accurate zzso patient profiles at diagnosis and during therapy to determine who would benefit most from a particular therapeutic regimen or to determine who should be shifted into more aggressive zzso We now have zzso methods of tumor cell detection that can determine the presence of minimal residual cancer zzso in zzso stem cell product zzso and zzso zzso to help create these zzso zzso The author has conducted a critical review of the literature regarding the type of testing used to detect zzso the zzso of zzso in zzso zzso and zzso zzso and the clinical significance of zzso at diagnosis and during zzso To date it is now clear that zzso is a very useful diagnostic tool with adequate sensitivity to detect zzso The presence of zzso at diagnosis in zzso and/or zzso zzso is associated with a poor prognosis for a number of disorders including breast cancer, zzso gastrointestinal tumors, and lung zzso In addition, the presence of zzso during therapy in zzso and/or SCP is associated with a very poor prognosis for patients with breast zzso The use of testing for zzso in the patient provides zzso information that may be of use to the zzso 

